You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NIH researchers got tantalizingly close to long-term engraftment at levels that could provide a clinical benefit in gene therapy applications.
There are a number of efforts underway to develop DNA vaccines for diseases like Zika, according to the Wall Street Journal.
The agency has committed $11 million for the creation of a network of research centers that will use systems biology approaches to build predictive models for infectious diseases.
The National Institute of Allergy and Infectious Diseases is seeking proposals for research into the three-dimensional atomic structures of pathogen proteins.
The researchers will use a new humanized mouse model to obtain genetic information at different life stages of the parasite.
Researchers put together an almost 2-billion-base genome assembly for the deer tick, which can transmit pathogens causing Lyme disease and other conditions.
An autosomal dominant form of vibratory urticaria has been linked to a missense mutation in the ADGRE2 gene that appears to affect mast cell function and inflammation.
A National Institutes of Health team demonstrated EBOV RNA can be found in semen using strategies approved for finding the virus in blood.
The partners will develop a multiplexed nucleic acid-based assay to detect carbapenem-resistant Enterobacteriaceae from whole blood samples.
Single-molecule sequencing of A. baumannii and Enterobacter species is uncovering the context and mechanics of antibacterial resistance.
A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.
A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.
The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.
In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.